[custom-menu name="topbar"] | [site-search]

Precision Diagnosis, Classification & Advanced Treatment

Genomic Tests

Genomic Tests

Comprehensive Genomic Profiling using Next-Generation Sequencing


Solid Tumors

Next Generation Sequencing DNA & RNA Testing


Tests Comparison


Hematologic Tumors

Next Generation Sequencing DNA & RNA Testing


Tests Comparison

Solid Tumors

Solid Tumor

Profile
434
Genes

  • TAT

    5-7 Days

  • Indications

    All solid tumors:
    Mutations in 434 genes,
    copy number variation and chromosomal structural abnormalities,
    TMB, MSI, HRD

  • Sample Type

    FFPE

  • Sample Requirements

    1 H&E slide and 6-8 unstained slides, 5-7 microns of tissue fixed with 10% NBF fixative

  • Results Reported

    DNA

  • Diagnostic
  • Therapeutic
  • Prognostic
  • Heterogeneity
  • Clinical Trial Matching

Read More
Learn more about this test

Solid Tumor Fusion / Expression Profile

1501
Genes

  • TAT

    7-10 Days

  • Indications

    ALL Solid tumors:
    Fusion: ALK, ROS1, RET, NTRK1/2/3, FGFR1/2/3/4, BRAF, CIC, EWSR1 and other sarcoma genes
    Expression: PD-L1, MYC, CCND1, MET, FGFR1/2/3/4, Ki67,
    ERBB2, MDM2
    Alternative splicing: MET exon 14 skipping, EGFR vIII , NTRK
    Mutations in all 1400 genes

  • Sample Type

    FFPE

  • Sample Requirements

    1 H&E slide and 6-8 unstained slides, 5-7 microns of tissue fixed with 10% NBF fixative

  • Results Reported

    RNA

  • Diagnostic
  • Therapeutic
  • Prognostic
  • Heterogeneity
  • Clinical Trial Matching

Read More
Learn more about this test

Solid Tumor

Profile Plus
434/1501
Genes

  • TAT

    7-10 Days

  • Indications

    ALK, ROS1, RET, NTRK1/2/3, BRAF, CIC, EWSR1, PD-L1,
    MET exon 14 skipping and various alternative splicing,
    MET, HER2,
    EGFR amplification,
    PIK3CA, PTEN, AKT1, RAS, HRD

  • Sample Type

    FFPE

  • Sample Requirements

    1 H&E slide and 6-8 unstained slides, 5-7 microns of tissue fixed with 10% NBF fixative

  • Results Reported

    DNA+RNA

  • Diagnostic
  • Therapeutic
  • Prognostic
  • Heterogeneity
  • Clinical Trial Matching

Read More
Learn more about this test
PLUS

Liquid Trace

Solid Tumor
284/1501
Genes

  • TAT

    5-7 Days

  • Indications

    Monitoring therapy,
    resistance and relapse

  • Sample Type

    Peripheral blood

  • Sample Requirements

    Peripheral blood: 5-10 ml.
    EDTA tube preferred

  • Results Reported

    DNA+RNA

  • Monitoring
  • Therapeutic
  • Prognostic
  • Heterogeneity
  • Clinical Trial Matching

Read More
Learn more about this test
Liquid Biopsy

Hematology

Hematology

Profile
284
Genes

  • TAT

    5-7 Days

  • Indications

    MDS, CMML, AML, MPN (JAK2, CALR, MPL), MRD, lymphoma, multiple myeloma, other hematologic diseases

  • Sample Type

    Bone marrow,
    Peripheral blood,
    Fresh tissue

  • Sample Requirements

    Bone marrow: 2ml.
    Peripheral blood: 5 ml.
    EDTA tube preferred
    FFPE: 1 H&E slide and 6-10 unstained slides, 5-7 microns of tissue fixed with 10% NBF fixative

  • Results Reported

    DNA

  • Diagnostic
  • Therapeutic
  • Prognostic
  • Heterogeneity
  • Clinical Trial Matching

Read More
Learn more about this test

Liquid Trace

Hematology Profile
284/1501
Genes

  • TAT

    5-7 Days

  • Indications

    Chromosomal abnormalities, gene amplifications, multiple myeloma, lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, MDS, CMML, AML, MPN, MRD, VEXAS syndrome, HPV, EBV

  • Sample Type

    Peripheral blood

  • Sample Requirements

    Peripheral blood: 5-10 ml.
    EDTA tube preferred

  • Results Reported

    DNA+RNA

  • Diagnostic
  • Therapeutic
  • Prognostic
  • Heterogeneity
  • Clinical Trial Matching

Read More
Learn more about this test

Hematology

Profile Plus
284/1501
Genes

  • TAT

    7-10 Days

  • Indications

    Classification and diagnosis of lymphoma, multiple myeloma, acute lymphoblastic leukemia, acute myeloid leukemia

    Includes IgVH

  • Sample Type

    Bone marrow,
    Peripheral blood,
    Fresh tissue

  • Sample Requirements

    Bone marrow: 2ml.
    Peripheral blood: 5 ml.
    EDTA tube preferred
    FFPE: 1 H&E slide and 6-10 unstained slides, 5-7 microns of tissue fixed with 10% NBF fixative

  • Results Reported

    DNA+RNA

  • Diagnostic
  • Therapeutic
  • Prognostic
  • Heterogeneity
  • Clinical Trial Matching

Read More
Learn more about this test
PLUS